Table 5.
Number (%) of patients with adverse events
| Number (%) patients, n = 54 | |
|---|---|
| Headache | 20 (37) |
| Cough | 12 (22) |
| Upper abdominal pain | 10 (19) |
| Nasal congestion | 10 (19) |
| Nasopharyngitis | 8 (15) |
| Pyrexia | 7 (13) |
| Rash | 6 (11) |
| Viral gastroenteritis | 5 (9) |
| Dizziness | 5 (9) |
| Psychomotor hyperactivity | 5 (9) |
| Nausea | 4 (7) |
| Pain in extremity | 4 (7) |
| Pharyngolaryngeal pain | 3 (6) |
| Constipation | 3 (6) |
| Stomach discomfort | 3 (6) |
| Vomiting | 3 (6) |
| Streptococcal pharyngitis | 3 (6) |
| Sinusitis | 3 (6) |
Adverse events reported in ≥5% of patients are listed.